EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A review of the pharmacology and clinical applications of levetiracetam in dogs and cats

Alicia Mastrocco iD, Jennifer Prittie iD, Chad West, Melissa Clark

Journal of Veterinary Emergency and Critical Care · 2024

DOI: 10.1111/vec.13355 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Veterinary Emergency and Critical Care, 2024. Verfasst von Alicia Mastrocco und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care, The Animal Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Cat Diseases, Dog Diseases, Epilepsy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 143 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To review and summarize the pharmacology of the antiepileptic drug (AED), levetiracetam (LEV), and to discuss its clinical utility in dogs and cats. Data Sources Veterinary and human peer‐reviewed medical literature and the authors’ clinical experience. Summary LEV is an AED with mechanisms of action distinct from those of other AEDs. In people and small animals, LEV exhibits linear kinetics, excellent oral bioavailability, and minimal drug–drug interactions. Serious side effects are rarely reported in any species. LEV use is gaining favor for treating epilepsy in small animals and may have wider clinical applications in patients with portosystemic shunts, neuroglycopenia, and traumatic brain injury. In people, LEV may improve cognitive function in patients with dementia.

Conclusion

LEV is a well‐tolerated AED with well‐documented efficacy in human patients. Although its use is becoming more common in veterinary medicine, its role as a first‐line monotherapy in small animal epileptics remains to be determined. This review of the human and animal literature regarding LEV describes its role in epileptic people and animals as well as in other disease states and provides recommendations for clinical usage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cat DiseasesDog DiseasesEpilepsyHumansCatsDogsAnimalsLevetiracetamAnticonvulsants

Stichwörter der Autor:innen

antiepilepticneurologyneuropharmacologyseizureveterinary

Substanzen

LevetiracetamAnticonvulsants

Autor:innen und Institutionen

  • Department of Emergency and Critical Care, The Animal Medical Center, New York, New York, USA.
  • Department of Neurology, The Animal Medical Center, New York, New York, USA.
  • Department of Internal Medicine, Gulf Coast Veterinary Specialists, Houston, Texas, USA.

ORCID-Profile: Alicia Mastrocco, Jennifer Prittie

Zitieren

APA

Mastrocco, A., Prittie, J., West, C., & Clark, M. (2024). A review of the pharmacology and clinical applications of levetiracetam in dogs and cats. Journal of Veterinary Emergency and Critical Care. https://doi.org/10.1111/vec.13355

Vancouver

Mastrocco A, Prittie J, West C, Clark M. A review of the pharmacology and clinical applications of levetiracetam in dogs and cats. Journal of Veterinary Emergency and Critical Care. 2024. doi:10.1111/vec.13355

BibTeX
@article{Mastrocco2024,
  author = {Mastrocco, Alicia and Prittie, Jennifer and West, Chad and Clark, Melissa},
  title = {A review of the pharmacology and clinical applications of levetiracetam in dogs and cats},
  journal = {Journal of Veterinary Emergency and Critical Care},
  year = {2024},
  doi = {10.1111/vec.13355}
}
Kostenlos starten →